Analyze Diet
Veterinary journal (London, England : 1997)2016; 218; 36-39; doi: 10.1016/j.tvjl.2016.11.003

Shortened egg reappearance after ivermectin or moxidectin use in horses in the UK.

Abstract: This study reports ivermectin and moxidectin egg reappearance periods (ERP) from UK horses with persistently positive faecal egg counts (FEC), defined as positive FEC within the ERP of an anthelmintic post-treatment, or with FECs that remained positive after the normal ERP post-anthelmintic treatment. A selected population of UK pleasure horses deemed at high risk of strongyle infection was studied. The earliest ERP recorded after ivermectin or moxidectin, using first positive FEC, was 5 weeks. From 16 premises where moxidectin was used, five had ERP ≥12 weeks using two further metrics. For premises where moxidectin was administered to only one animal (present or tested), and evaluated as one group (n = 61), ERP was ≥10 weeks. For premises where ivermectin was used, the ERP was ≥5 weeks. Premises with only one horse (present or tested), dosed with ivermectin (n = 31), analysed as one group, demonstrated egg reappearance ≥6 weeks. These field data suggest shortened ERPs following macrocyclic lactone treatment compared to previously published values (8-10 and >13 weeks respectively) when these drugs were first marketed.
Publication Date: 2016-11-14 PubMed ID: 27938707DOI: 10.1016/j.tvjl.2016.11.003Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research article focuses on the study of the reappearance of eggs (ERP) after the use of ivermectin or moxidectin in horses in the UK, specifically those with a persistent positive faecal egg count (FEC), indicating an indication of strongyle infection. The study concluded that the egg reappearance period is shorter than previously believed.

Overview

  • The study involves an examination of UK horses deemed at high risk of strongyle infection. The predictors were the usage of either ivermectin or moxidectin and the time period after which faecal egg count returns to positive. Also, the researchers looked at cases where FEC remained positive, even after the normal expected egg reappearance period (ERP) post-treatment.

Selection of Premises and Horses

  • The study focused primarily on pleasure horses from the UK believed to be at a significantly high risk of strongyle infection.
  • There were different scenarios studied. On 16 premises where moxidectin was used, five recorded an ERP of at least 12 weeks as per two different measuring metrics.
  • On the premises where moxidectin was administered to only one animal and evaluated as a group, the ERP recorded was at least 10 weeks.

Ivermectin Use and ERP

  • For premises where ivermectin was employed, the ERP was a minimum of 5 weeks.
  • In places where only one horse was present or tested, and ivermectin was used, when analyzed as a group, showed an ERP of at least 6 weeks.

Significance of the Research Findings

  • The research data presents a shortened egg reappearance period following the treatment with macrocyclic lactones (ivermectin or moxidectin) as compared to the previously published values. When these drugs were first marketed, the ERP was expected to be between 8-10 weeks for ivermectin and more than 13 weeks for moxidectin.
  • This significantly alters the understanding and handling of strongyle infections in horses and could impact the administration of these drugs for the treatment of such infections.

Cite This Article

APA
Daniels SP, Proudman CJ. (2016). Shortened egg reappearance after ivermectin or moxidectin use in horses in the UK. Vet J, 218, 36-39. https://doi.org/10.1016/j.tvjl.2016.11.003

Publication

ISSN: 1532-2971
NlmUniqueID: 9706281
Country: England
Language: English
Volume: 218
Pages: 36-39
PII: S1090-0233(16)30188-5

Researcher Affiliations

Daniels, S P
  • School of Equine Management and Science, Royal Agricultural University, Cirencester, Gloucestershire GL7 6JS, UK; School of Veterinary Medicine, University of Surrey, Guildford, Surrey GU2 7TE, UK. Electronic address: simon.daniels@rau.ac.uk.
Proudman, C J
  • School of Veterinary Medicine, University of Surrey, Guildford, Surrey GU2 7TE, UK.

MeSH Terms

  • Animals
  • Antinematodal Agents / therapeutic use
  • Feces / parasitology
  • Female
  • Horses
  • Male
  • Ovum / drug effects
  • Parasite Egg Count / veterinary
  • Strongyle Infections, Equine / epidemiology
  • Strongyle Infections, Equine / parasitology
  • Strongyle Infections, Equine / prevention & control
  • Strongyloidea / drug effects
  • Strongyloidea / physiology
  • United Kingdom / epidemiology

Citations

This article has been cited 9 times.